Heart attack; Chest discomfort; Cough; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack), COUGH (Cough) and CHEST DISCOMFORT (Chest discomfort) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Ulcerative colitis.    The patient's past medical history included Non-tobacco user. Concurrent medical conditions included Drug allergy and Ulcerative colitis. Concomitant products included MELOXICAM for Arthritis, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE (NEXIUM [ESOMEPRAZOLE MAGNESIUM TRIHYDRATE]) for Gastrooesophageal reflux disease, ROSUVASTATIN for Hyperlipidaemia, ROSUVASTATIN CALCIUM (CRESTOR) for Hyperlipidemia, VALSARTAN for Hypertension, DOXEPIN for Sleep disorder, Anxiety and Depression, RIVAROXABAN (XARELTO) and CLOPIDOGREL BISULFATE (PLAVIX) for an unknown indication.   On 06-Jan-2017, the patient ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to 40 milligram every two weeks. On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. In 2021, the patient experienced COUGH (Cough) (seriousness criterion hospitalization). On 25-Oct-2021, the patient experienced CHEST DISCOMFORT (Chest discomfort) (seriousness criterion hospitalization). In December 2021, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criteria hospitalization and medically significant). At the time of the report, MYOCARDIAL INFARCTION (Heart attack) had resolved and COUGH (Cough) and CHEST DISCOMFORT (Chest discomfort) outcome was unknown.            No treatment medication was reported. Patient had chest pain started 30 minutes after received booster vaccine. The patient's ethnic origin was reported. On 23Nov2021 patient had open heart bypass surgery. This case was identified as a part of a retrospective email clean-up activity which included identification and booking-in of historical emails. This activity has been described in deviation.  Company comment  This spontaneous case reported by a consumer, concerns a 70 year old male patient, with no relevant medical history reported, who experienced the unexpected, serious (Hospitalization, medically significant) event of MYOCARDIAL INFARCTION (Heart attack), on an unknown date, about 1 month after receiving the 3 dose of Moderna vaccine and the unexpected, serious events of CHEST DISCOMFORT(medically significant) and the non serious event of cough on the same day after receiving the 3 dose of Moderna mRNA1273 vaccine, in the covid 19 vaccination series. Patient had chest pain, 30 minutes after receiving the booster dose of vaccine. Patient had open heart bypass surgery about a month later. It was reported that the patient had received ADALIMUMAB (HUMIRA) injection for Ulcerative Colitis. Relevant concomitant medications included, ROSUVASTATIN CALCIUM for Hyperlipidemia, VALSARTAN for Hypertension, DOXEPIN for Sleep disorder, Anxiety and Depression, RIVAROXABAN and CLOPIDOGREL BISULFATE for an unknown indication. All these treatment indications are significant risk factors for the event. The outcome of Myocardial Infarction was resolved. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case reported by a consumer, concerns a 70 year old male patient, with no relevant medical history reported, who experienced the unexpected, serious (Hospitalization, medically significant) event of MYOCARDIAL INFARCTION (Heart attack), on an unknown date, about 1 month after receiving the 3 dose of Moderna vaccine and the unexpected, serious events of CHEST DISCOMFORT(medically significant) and the non serious event of cough on the same day after receiving the 3 dose of Moderna mRNA1273 vaccine, in the covid 19 vaccination series. Patient had chest pain, 30 minutes after receiving the booster dose of vaccine. Patient had open heart bypass surgery about a month later. It was reported that the patient had received ADALIMUMAB (HUMIRA) injection for Ulcerative Colitis. Relevant concomitant medications included, ROSUVASTATIN CALCIUM for Hyperlipidemia, VALSARTAN for Hypertension, DOXEPIN for Sleep disorder, Anxiety and Depression, RIVAROXABAN and CLOPIDOGREL BISULFATE for an unknown indication. All these treatment indications are significant risk factors for the event. The outcome of Myocardial Infarction was resolved. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.